Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma.
Seneviratne JA, Ravindrarajah D, Carter DR, Zhai V, Lalwani A, Krishan S, Balachandran A, Ng E, Pandher R, Wong M, Nero TL, Wang S, Norris MD, Haber M, Liu T, Parker MW, Cheung BB, Marshall GM.
Seneviratne JA, et al. Among authors: lalwani a.
Cancer Med. 2024 Nov;13(21):e70082. doi: 10.1002/cam4.70082.
Cancer Med. 2024.
PMID: 39501501
Free PMC article.